Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 11 | $6,552,561 |
| Sells | 112 | $90,577,092 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 17 Sep 2024 18:20 | KYMR | Kymera Therapeutics Inc | ESPOSITO PAMELA | Director | 17 Sep 2024 | Sale | 7,150 | 48.7526 | 348,581 | D |
| 17 Sep 2024 18:20 | KYMR | Kymera Therapeutics Inc | ESPOSITO PAMELA | Director | 17 Sep 2024 | Sale | 6,350 | 47.7456 | 303,185 | D |
| 26 Aug 2024 18:31 | KYMR | Kymera Therapeutics Inc | ALBERS JEFFREY W. | Director | 26 Aug 2024 | Sale | 5,000 | 49.1017 | 245,508 | D |
| 22 Aug 2024 16:03 | KYMR | Kymera Therapeutics Inc | BAKER BROS. ADVISORS LP | Director | 20 Aug 2024 | Purchase | 1 | 46.41 | 46 | I |
| 16 Jul 2024 18:00 | KYMR | Kymera Therapeutics Inc | GOLLOB JARED | Chief Medical Officer | 16 Jul 2024 | Sale | 9,864 | 46.0965 | 454,696 | D |
| 16 Jul 2024 18:00 | KYMR | Kymera Therapeutics Inc | GOLLOB JARED | Chief Medical Officer | 16 Jul 2024 | Sale | 13,281 | 45.5931 | 605,522 | D |
| 16 Jul 2024 18:00 | KYMR | Kymera Therapeutics Inc | GOLLOB JARED | Chief Medical Officer | 15 Jul 2024 | Sale | 16,455 | 45.1489 | 742,925 | D |
| 09 Jul 2024 17:15 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 09 Jul 2024 | Sale | 20,238 | 39.26 | 794,544 | I |
| 09 Jul 2024 17:15 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 09 Jul 2024 | Sale | 38,606 | 38.48 | 1,485,559 | I |
| 09 Jul 2024 17:15 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 09 Jul 2024 | Sale | 8,769 | 37.41 | 328,048 | I |
| 09 Jul 2024 17:15 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 09 Jul 2024 | Sale | 6,030 | 36.4 | 219,492 | I |
| 09 Jul 2024 17:15 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 09 Jul 2024 | Sale | 5,133 | 35.57 | 182,581 | I |
| 09 Jul 2024 17:15 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 09 Jul 2024 | Sale | 96,386 | 39.26 | 3,784,114 | I |
| 09 Jul 2024 17:15 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 09 Jul 2024 | Sale | 183,868 | 38.48 | 7,075,241 | I |
| 09 Jul 2024 17:15 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 09 Jul 2024 | Sale | 28,718 | 36.4 | 1,045,335 | I |
| 09 Jul 2024 17:15 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 09 Jul 2024 | Sale | 41,763 | 37.41 | 1,562,354 | I |
| 09 Jul 2024 17:15 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 09 Jul 2024 | Sale | 24,449 | 35.57 | 869,651 | I |
| 14 Jun 2024 18:01 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 13 Jun 2024 | Sale | 1,770 | 34.98 | 61,915 | I |
| 14 Jun 2024 18:01 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 13 Jun 2024 | Sale | 8,430 | 34.98 | 294,881 | I |
| 14 Jun 2024 18:01 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 12 Jun 2024 | Sale | 420 | 36.02 | 15,128 | I |
| 14 Jun 2024 18:01 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 12 Jun 2024 | Sale | 2,485 | 35.35 | 87,845 | I |
| 14 Jun 2024 18:01 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 12 Jun 2024 | Sale | 1,997 | 36.02 | 71,932 | I |
| 14 Jun 2024 18:01 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 12 Jun 2024 | Sale | 11,838 | 35.35 | 418,473 | I |
| 07 Jun 2024 18:36 | KYMR | Kymera Therapeutics Inc | HOROBIN JOANNA | Director | 07 Jun 2024 | Sale | 6,313 | 33.1071 | 209,005 | D |
| 07 Jun 2024 18:36 | KYMR | Kymera Therapeutics Inc | HOROBIN JOANNA | Director | 07 Jun 2024 | Sale | 2,187 | 32.6451 | 71,395 | D |
| 23 May 2024 16:10 | KYMR | Kymera Therapeutics Inc | CHADWICK JEREMY G | Chief Operating Officer | 23 May 2024 | Sale | 2,575 | 34.9921 | 90,105 | D |
| 15 Mar 2024 19:23 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 15 Mar 2024 | Sale | 329 | 41.23 | 13,565 | I |
| 15 Mar 2024 19:23 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 15 Mar 2024 | Sale | 10,411 | 40.62 | 422,895 | I |
| 15 Mar 2024 19:23 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 15 Mar 2024 | Sale | 1,714 | 39.31 | 67,377 | I |
| 15 Mar 2024 19:23 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 15 Mar 2024 | Sale | 1,593 | 41.23 | 65,679 | I |
| 15 Mar 2024 19:23 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 15 Mar 2024 | Sale | 49,591 | 40.62 | 2,014,386 | I |
| 15 Mar 2024 19:23 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 15 Mar 2024 | Sale | 8,126 | 39.31 | 319,433 | I |
| 15 Mar 2024 19:23 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 14 Mar 2024 | Sale | 154 | 41.51 | 6,393 | I |
| 15 Mar 2024 19:23 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 14 Mar 2024 | Sale | 2,233 | 40.66 | 90,794 | I |
| 15 Mar 2024 19:23 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 14 Mar 2024 | Sale | 7,292 | 39.73 | 289,711 | I |
| 15 Mar 2024 19:23 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 14 Mar 2024 | Sale | 781 | 41.51 | 32,419 | I |
| 15 Mar 2024 19:23 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 14 Mar 2024 | Sale | 10,846 | 40.66 | 440,998 | I |
| 15 Mar 2024 19:23 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 14 Mar 2024 | Sale | 34,473 | 39.73 | 1,369,612 | I |
| 13 Mar 2024 19:53 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 13 Mar 2024 | Sale | 22,779 | 42.19 | 961,046 | I |
| 13 Mar 2024 19:53 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 13 Mar 2024 | Sale | 1,386 | 42.84 | 59,376 | I |
| 13 Mar 2024 19:53 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 13 Mar 2024 | Sale | 6,686 | 42.84 | 286,428 | D |
| 13 Mar 2024 19:53 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 13 Mar 2024 | Sale | 108,404 | 42.19 | 4,573,565 | D |
| 13 Mar 2024 19:53 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 12 Mar 2024 | Sale | 1,819 | 42.52 | 77,344 | I |
| 13 Mar 2024 19:53 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 12 Mar 2024 | Sale | 26,452 | 41.94 | 1,109,397 | I |
| 13 Mar 2024 19:53 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 12 Mar 2024 | Sale | 8,581 | 42.52 | 364,864 | D |
| 13 Mar 2024 19:53 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 12 Mar 2024 | Sale | 126,066 | 41.94 | 5,287,208 | D |
| 13 Mar 2024 19:53 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 11 Mar 2024 | Sale | 1,045 | 43.42 | 45,374 | I |
| 13 Mar 2024 19:53 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 11 Mar 2024 | Sale | 7,837 | 42.77 | 335,188 | I |
| 13 Mar 2024 19:53 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 11 Mar 2024 | Sale | 5,122 | 43.42 | 222,397 | D |
| 13 Mar 2024 19:53 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 11 Mar 2024 | Sale | 37,180 | 42.77 | 1,590,189 | D |
| 13 Mar 2024 19:52 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 11 Mar 2024 | Sale | 37,180 | 42.77 | 1,590,189 | I |
| 13 Mar 2024 19:52 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 11 Mar 2024 | Sale | 5,122 | 43.42 | 222,397 | I |
| 13 Mar 2024 19:52 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 11 Mar 2024 | Sale | 7,837 | 42.77 | 335,188 | I |
| 13 Mar 2024 19:52 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 11 Mar 2024 | Sale | 1,045 | 43.42 | 45,374 | I |
| 13 Mar 2024 19:52 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 12 Mar 2024 | Sale | 126,066 | 41.94 | 5,287,208 | I |
| 13 Mar 2024 19:52 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 12 Mar 2024 | Sale | 8,581 | 42.52 | 364,864 | I |
| 13 Mar 2024 19:52 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 12 Mar 2024 | Sale | 26,452 | 41.94 | 1,109,397 | I |
| 13 Mar 2024 19:52 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 12 Mar 2024 | Sale | 1,819 | 42.52 | 77,344 | I |
| 13 Mar 2024 19:52 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 13 Mar 2024 | Sale | 108,404 | 42.19 | 4,573,565 | I |
| 13 Mar 2024 19:52 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 13 Mar 2024 | Sale | 6,686 | 42.84 | 286,428 | I |
| 13 Mar 2024 19:52 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 13 Mar 2024 | Sale | 22,779 | 42.19 | 961,046 | I |
| 13 Mar 2024 19:52 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 13 Mar 2024 | Sale | 1,386 | 42.84 | 59,376 | I |
| 04 Mar 2024 18:21 | KYMR | Kymera Therapeutics Inc | GOLLOB JARED | Chief Medical Officer | 04 Mar 2024 | Sale | 216 | 43.2564 | 9,343 | D |
| 04 Mar 2024 18:21 | KYMR | Kymera Therapeutics Inc | GOLLOB JARED | Chief Medical Officer | 04 Mar 2024 | Sale | 1,106 | 42.3924 | 46,886 | D |
| 04 Mar 2024 18:21 | KYMR | Kymera Therapeutics Inc | GOLLOB JARED | Chief Medical Officer | 04 Mar 2024 | Sale | 2,022 | 41.4135 | 83,738 | D |
| 04 Mar 2024 18:12 | KYMR | Kymera Therapeutics Inc | JACOBS BRUCE N. | Chief Financial Officer | 04 Mar 2024 | Sale | 255 | 43.2564 | 11,030 | D |
| 04 Mar 2024 18:12 | KYMR | Kymera Therapeutics Inc | JACOBS BRUCE N. | Chief Financial Officer | 04 Mar 2024 | Sale | 1,301 | 42.3924 | 55,153 | D |
| 04 Mar 2024 18:12 | KYMR | Kymera Therapeutics Inc | JACOBS BRUCE N. | Chief Financial Officer | 04 Mar 2024 | Sale | 2,378 | 41.4135 | 98,481 | D |
| 29 Feb 2024 16:34 | KYMR | Kymera Therapeutics Inc | GOLLOB JARED | Chief Medical Officer | 27 Feb 2024 | Sale | 400 | 45 | 18,000 | D |
| 21 Feb 2024 18:46 | KYMR | Kymera Therapeutics Inc | ALBERS JEFFREY W. | Director | 21 Feb 2024 | Sale | 4,385 | 39.0483 | 171,227 | D |
| 21 Feb 2024 18:46 | KYMR | Kymera Therapeutics Inc | ALBERS JEFFREY W. | Director | 20 Feb 2024 | Sale | 615 | 39.0746 | 24,031 | D |
| 09 Feb 2024 19:47 | KYMR | Kymera Therapeutics Inc | GOLLOB JARED | Chief Medical Officer | 09 Feb 2024 | Sale | 7,398 | 36.0926 | 267,013 | D |
| 09 Feb 2024 19:47 | KYMR | Kymera Therapeutics Inc | GOLLOB JARED | Chief Medical Officer | 09 Feb 2024 | Sale | 38,739 | 35.3922 | 1,371,058 | D |
| 23 Jan 2024 19:37 | KYMR | Kymera Therapeutics Inc | ALBERS JEFFREY W. | Director | 23 Jan 2024 | Sale | 10,000 | 30.047 | 300,470 | D |
| 05 Jan 2024 17:15 | KYMR | Kymera Therapeutics Inc | CHINIARA ELLEN | Chief Legal Officer | 04 Jan 2024 | Sale | 3,295 | 22.5844 | 74,416 | D |
| 06 Nov 2023 18:07 | KYMR | Kymera Therapeutics Inc | BVF PARTNERS L P/IL | Director | 03 Nov 2023 | Purchase | 10,106 | 14.0689 | 142,180 | D |
| 06 Nov 2023 18:07 | KYMR | Kymera Therapeutics Inc | BVF PARTNERS L P/IL | Director | 03 Nov 2023 | Purchase | 103,885 | 14.0689 | 1,461,548 | D |
| 06 Nov 2023 18:07 | KYMR | Kymera Therapeutics Inc | BVF PARTNERS L P/IL | Director | 03 Nov 2023 | Purchase | 83,708 | 14.0689 | 1,177,679 | D |
| 06 Nov 2023 18:07 | KYMR | Kymera Therapeutics Inc | BVF PARTNERS L P/IL | Director | 02 Nov 2023 | Purchase | 26,772 | 11.6444 | 311,744 | D |
| 06 Nov 2023 18:07 | KYMR | Kymera Therapeutics Inc | BVF PARTNERS L P/IL | Director | 02 Nov 2023 | Purchase | 132,016 | 11.6444 | 1,537,247 | D |
| 06 Nov 2023 18:07 | KYMR | Kymera Therapeutics Inc | BVF PARTNERS L P/IL | Director | 02 Nov 2023 | Purchase | 57,618 | 11.6444 | 670,927 | D |
| 03 Mar 2023 16:31 | KYMR | Kymera Therapeutics Inc | CAUGHEY ELAINE | Chief Business Officer | 02 Mar 2023 | Sale | 164 | 31.3973 | 5,149 | D |
| 03 Mar 2023 16:31 | KYMR | Kymera Therapeutics Inc | CAUGHEY ELAINE | Chief Business Officer | 02 Mar 2023 | Sale | 550 | 30.8774 | 16,983 | D |
| 03 Mar 2023 16:30 | KYMR | Kymera Therapeutics Inc | GOLLOB JARED | Chief Medical Officer | 02 Mar 2023 | Sale | 297 | 31.3973 | 9,325 | D |
| 03 Mar 2023 16:30 | KYMR | Kymera Therapeutics Inc | GOLLOB JARED | Chief Medical Officer | 02 Mar 2023 | Sale | 1,001 | 30.8774 | 30,908 | D |
| 03 Mar 2023 16:30 | KYMR | Kymera Therapeutics Inc | JACOBS BRUCE N. | Chief Financial Officer | 02 Mar 2023 | Sale | 314 | 31.3973 | 9,859 | D |
| 03 Mar 2023 16:30 | KYMR | Kymera Therapeutics Inc | JACOBS BRUCE N. | Chief Financial Officer | 02 Mar 2023 | Sale | 1,056 | 30.8774 | 32,607 | D |
| 13 Jan 2023 17:08 | KYMR | Kymera Therapeutics Inc | BVF PARTNERS L P/IL | Director | 12 Jan 2023 | Purchase | 15,912 | 31.2426 | 497,132 | D |
| 13 Jan 2023 17:08 | KYMR | Kymera Therapeutics Inc | BVF PARTNERS L P/IL | Director | 12 Jan 2023 | Purchase | 2,985 | 31.2426 | 93,259 | D |
| 13 Jan 2023 17:08 | KYMR | Kymera Therapeutics Inc | BVF PARTNERS L P/IL | Director | 11 Jan 2023 | Purchase | 11,149 | 29.8869 | 333,209 | D |
| 13 Jan 2023 17:08 | KYMR | Kymera Therapeutics Inc | BVF PARTNERS L P/IL | Director | 11 Jan 2023 | Purchase | 10,961 | 29.8869 | 327,590 | D |
| 13 Jan 2023 16:53 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 12 Jan 2023 | Sale | 21,592 | 30.29 | 654,022 | I |
| 13 Jan 2023 16:53 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 12 Jan 2023 | Sale | 77,128 | 30.29 | 2,336,207 | I |
| 13 Jan 2023 16:53 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 11 Jan 2023 | Sale | 6,071 | 29.96 | 181,887 | I |
| 13 Jan 2023 16:53 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 11 Jan 2023 | Sale | 21,683 | 29.96 | 649,623 | I |
| 13 Jan 2023 16:50 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 12 Jan 2023 | Sale | 21,592 | 30.29 | 654,022 | I |
| 13 Jan 2023 16:50 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 12 Jan 2023 | Sale | 77,128 | 30.29 | 2,336,207 | D |
| 13 Jan 2023 16:50 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 11 Jan 2023 | Sale | 6,071 | 29.96 | 181,887 | I |
| 13 Jan 2023 16:50 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 11 Jan 2023 | Sale | 21,683 | 29.96 | 649,623 | D |
| 16 Dec 2022 17:05 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 15 Dec 2022 | Sale | 717 | 30 | 21,510 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)